MarketPeel
Insider Trading Intelligence
CM

Connie Matsui

ARTL
DIRECTOR · ARTELO BIOSCIENCES, INC. · CIK 0001236537
FILING MIX · LIFETIME74%/26%
BUYS
32
SELLS
11
TOTAL VALUE
$2.25M
COMPANIES
3
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
193,327
AVG SELL PX
$33.72
TRADE KIND
SHOWING 43 / 43
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Connie Matsui, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%+8.00%+0.59%+7.40%+0.49%
14d6+66.67%-1.55%+2.01%-3.56%-12.29%
30d6+83.33%-1.02%+3.07%-4.09%-1.90%
60d6+66.67%+30.77%+5.76%+25.01%+10.53%
90d6+66.67%+25.28%+5.98%+19.30%+10.29%
180d6+16.67%+32.02%+7.38%+24.65%+9.53%
1y6(1 pending)+20.00%+0.31%+15.28%-14.96%+17.13%
2y6(2 pending)+50.00%-10.11%+18.55%-28.66%-9.28%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARTL · 292 shares · as of Jan 30, 2026
039,87579,750119,625159,500202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 32 buys / 11 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 5, 2026Jun 9, 2026View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
292292Jan 30, 2026Feb 2, 2026View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
1,5001,500Dec 23, 2025Dec 29, 2025View →
ARTL
ARTELO BIOSCIENCES, INC.
SALE
$140,000.00Oct 28, 2025Oct 30, 2025View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASE
38,34638,346Oct 28, 2025Oct 30, 2025View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASE
$110,843.00Oct 28, 2025Oct 30, 2025View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASE
70,37670,376Oct 28, 2025Oct 30, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
50,000$0.80$40.0K50,000Oct 15, 2025Oct 16, 2025View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 6, 2025Jun 10, 2025View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASE
$140,000.00May 1, 2025May 5, 2025View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,7501,750Dec 20, 2024Dec 23, 2024View →
HALO
HALOZYME THERAPEUTICS, INC.
SALEGRANT
Gift
10,470183,035Nov 29, 2024Dec 3, 2024View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
35,00035,000Jun 6, 2024Jun 10, 2024View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,8048,804Apr 25, 2024Apr 29, 2024View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,501193,505Apr 25, 2024Apr 29, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
667667Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
SALE
6670Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
SALE
1,0830Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,0831,083Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
SALE
1,7670Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,7671,767Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
SALE
10,6340Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
10,63410,634Feb 28, 2024Mar 1, 2024View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
1,0831,083Aug 4, 2023Aug 8, 2023View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
667667Jun 30, 2023Jul 3, 2023View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 8, 2023Jun 12, 2023View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,37111,371May 5, 2023May 9, 2023View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,065187,004May 5, 2023May 9, 2023View →
HALO
HALOZYME THERAPEUTICS, INC.
SALEGRANT
Gift
9,250178,939Nov 16, 2022Nov 17, 2022View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 24, 2022Jun 27, 2022View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
18,50018,500Jun 6, 2022Jun 8, 2022View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,206188,189May 5, 2022May 6, 2022View →
HALO
HALOZYME THERAPEUTICS, INC.
SALE
19,452$40.13$780.5K194,531Nov 5, 2021Nov 5, 2021View →
HALO
HALOZYME THERAPEUTICS, INC.
SALE
12,548$40.77$511.6K181,983Nov 5, 2021Nov 5, 2021View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jul 16, 2021Jul 26, 2021View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
18,50018,500Jun 3, 2021Jun 7, 2021View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,230213,983May 5, 2021May 6, 2021View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
159,500159,500Feb 12, 2021Feb 17, 2021View →
HALO
HALOZYME THERAPEUTICS, INC.
SALEGRANT
Gift
8,000208,753Sep 14, 2020Sep 14, 2020View →
HALO
HALOZYME THERAPEUTICS, INC.
SALE
32,000$27.06$865.8K216,753Sep 11, 2020Sep 14, 2020View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
12,00012,000Jun 5, 2020Jun 8, 2020View →
ARTL
ARTELO BIOSCIENCES, INC.
PURCHASE
41,667$1.20$50.0K56,667May 4, 2020May 4, 2020View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,829248,753Apr 30, 2020May 1, 2020View →
Other insiders · ARTL
Loading peer insiders…
About this filer
CIK 0001236537
ROLE
Director
PRIMARY
ARTL
COMPANIES
3
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001236537DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback